RAFAEL MARÍA
CANTÓN MORENO
Profesor asociado
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Sevilla (7)
2021
-
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic
Journal of Global Antimicrobial Resistance, Vol. 25, pp. 5-7
-
Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance
Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 115, Núm. 10, pp. 1122-1129
2017
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
-
MIC of amoxicillin/clavulanate according to CLSI and EUCAST: Discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 5, pp. 1478-1487
2016
-
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Mayo Clinic Proceedings, Vol. 91, Núm. 10, pp. 1362-1371
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: The Bacteraemia-MIC project
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 521-530